ADBiotech Co

ADBiotech Co Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of ADBiotech Co (179530.KQ) as of Nov 22, 2026 is 27.92. In the previous year, Cash Conversion Cycle (CCC) was 132.44 — a change of -78.92% (lower).

Cash Conversion Cycle

27.92

YoY

-78.92%

Last updated:

Cash Conversion Cycle (CCC) of ADBiotech Co is 2025 27.92 . Cash Conversion Cycle (CCC) of ADBiotech Co was 2024 132.44 . It decreases by -78.92% lower compared to the previous year.

The ADBiotech Co Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
200.37 KRW
Jan 1, 2019
222.81 KRW
Jan 1, 2020
151.42 KRW
Jan 1, 2021
160.74 KRW
Jan 1, 2022
203.75 KRW
Jan 1, 2023
157.23 KRW
Jan 1, 2024
132.44 KRW
Jan 1, 2025
27.92 KRW
The ADBiotech Co Cash Conversion Cycle history
YEARCash Conversion CycleYoY
27.92-78.92%
132.44-15.77%
157.23-22.83%
203.75+26.76%
160.74+6.15%
151.42-32.04%
222.81+11.20%
200.37-3.59%
207.82+29.38%
160.63—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

Cash Conversion Cycle (CCC) of ADBiotech Co is 27.92 in 2025.

Cash Conversion Cycle (CCC) of ADBiotech Co changed from 132.44 to 27.92, representing a -78.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s ADBiotech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ADBiotech Co

All Key Metrics — ADBiotech Co